ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE
Other Solid Tumors
Memorial Sloan Kettering Cancer Centergene_therapyPhase 2Dormant
B
56/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 41/ 100
- Competitive Position
- 81/ 100
Competitive context
29 Active assets in the Other Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide National University Hospital, Singapore | Phase 1/2 | B |
Epirubicin Karyopharm Therapeutics Inc | Phase 1/2 | B |
Pembrolizumab Evopoint Biosciences Inc. | Phase 1/2 | B |
Fludarabine National University Hospital, Singapore | Phase 1/2 | CCC |
Calcium folinate pentahydrate Karyopharm Therapeutics Inc | Phase 1/2 | CCC |
View all 46 →
Same molecule, other indications
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →